ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,798.84
0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) News

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNCE
DateTimeSourceHeadlineSymbolCompany
16/03/202313:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202321:06Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202321:03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202312:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202322:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202319:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202314:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Your Recent History

DBI
DAX
DAX
FX
JPYUSD
Yen vs US Dollar
LSE
RCGH
Rc365
LSE
BATS
British American Tobacco
LSE
EEE
Empire Metals
LSE
OBD
Oxford Biodynamics
LSE
YU.
Yu
LSE
EME
Empyrean Energy
LSE
XPP
Xp Power
LSE
HARL
Harland & Wolff
LSE
AVCT
Avacta
LSE
OXB
Oxford Biomedica
NYSE
GE
GE Aerospace
LSE
BT.A
Bt
LSE
ENQ
Enquest
LSE
NG.
National Grid
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved